Breast cancers arising in female BRCA1 mutation carriers display characteristic pathologic features, including distinct morphology (i.e., carcinomas with medullary features) and a triple-negative phenotype [i.e., ER−, PR−, human epidermal growth factor receptor 2–negative (HER2−)] in the majority. The gene discussed is ERBB2; the disease is breast carcinoma.